Related Experiment Video
Updated: May 15, 2026
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Structure and dynamic regulation of Abl kinases
Shoghag Panjarian1, Roxana E Iacob, Shugui Chen
1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15219, USA.
The Journal of Biological Chemistry
|January 15, 2013
Summary
The Abl kinase, crucial in cancer and cell regulation, has a structure that impacts how drugs like imatinib work. Understanding Abl kinase dynamics is key for developing better targeted cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- The c-abl proto-oncogene encodes the Abl protein-tyrosine kinase, vital for cellular responses to genotoxic stress and actin cytoskeleton regulation.
- Abl kinase is implicated in chronic myelogenous leukemia through the Bcr-Abl fusion protein.
- Targeted therapies, like imatinib, have transformed chronic myelogenous leukemia treatment.
Purpose of the Study:
- To review the structural organization and dynamics of Abl kinases.
- To explore how these structural features influence sensitivity to kinase inhibitors.
Main Methods:
- Structural analysis of Abl kinases.
- Review of existing literature on Abl kinase dynamics and inhibitor interactions.
Main Results:
- Abl kinase possesses unique structural features differentiating it from other cytoplasmic tyrosine kinases.
- The structural dynamics of Abl kinases are critical determinants of their sensitivity to selective inhibitors.
- Imatinib's efficacy is linked to its interaction with specific conformations of the Bcr-Abl kinase domain.
Conclusions:
- Understanding Abl kinase structure-dynamics is essential for rational drug design in targeted cancer therapy.
- Further research into Abl kinase conformational states can lead to improved inhibitor strategies for Bcr-Abl-driven malignancies and potentially other cancers.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...